Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperhomocysteinemia and venous thrombosis

G M Bos1, M den Heijer

  • 1University Hospital Rotterdam/Daniel den Hoed Cancer Center, The Netherlands.

Seminars in Thrombosis and Hemostasis
|October 8, 1998
PubMed
Summary

Hyperhomocysteinemia is a risk factor for vascular issues like venous thrombosis. While easily treated with vitamins, ongoing studies investigate if lowering homocysteine levels prevents recurrent thrombosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Psychological and physical effects of short-term discontinuation of feminizing gender-affirming hormone therapy among older transgender women: a within-subject clinical trial.

Human reproduction (Oxford, England)·2026
Same author

Associations between estradiol levels and subjective sleep parameters in a large cohort of men and women.

Endocrine connections·2026
Same author

Recognition, prevalence and prevention of falsely high serum testosterone concentrations in testosterone gel users.

Clinica chimica acta; international journal of clinical chemistry·2025
Same author

The effect of circulating iron on barrier integrity of primary human endothelial cells.

Scientific reports·2023
Same author

Effects of hormonal treatment on dermatological outcome in transgender people: a multicentric prospective study (ENIGI).

Journal of endocrinological investigation·2022
Same author

Standards of Care for the Health of Transgender and Gender Diverse People, Version 8.

International journal of transgender health·2022

Area of Science:

  • Cardiovascular Medicine
  • Thrombosis Research

Background:

  • Hyperhomocysteinemia is increasingly recognized as a risk factor for various conditions, including neural tube defects, arterial cardiovascular disease, and venous thrombosis.
  • The association between hyperhomocysteinemia and vascular diseases, particularly venous thrombosis, has garnered significant attention.

Purpose of the Study:

  • To discuss hyperhomocysteinemia, its causes, and its association with venous thrombosis.
  • To evaluate the diagnostic utility of the methionine loading test for hyperhomocysteinemia.
  • To explore therapeutic options and ongoing research into the clinical relevance of lowering homocysteine levels for preventing recurrent venous thrombosis.

Main Methods:

  • Review of existing case-control and prospective studies on hyperhomocysteinemia and venous thrombosis.
  • Discussion of potential mechanisms linking hyperhomocysteinemia to venous thrombosis.
  • Description of a current international multicenter, placebo-controlled study investigating the efficacy of homocysteine level reduction.

Main Results:

  • Several case-control studies suggest an association between venous thrombosis and hyperhomocysteinemia.
  • Evidence for a causal relationship, especially for mild hyperhomocysteinemia, remains limited.
  • Hyperhomocysteinemia is generally treatable with vitamin supplementation.

Conclusions:

  • While an association exists, the causal role of mild hyperhomocysteinemia in venous thrombosis requires further investigation.
  • Ongoing research aims to determine the clinical significance of reducing homocysteine levels in preventing recurrent venous thrombosis.

Related Experiment Videos